GLP-1s, Medicare & Medicaid: BALANCE Model Explained

Medicare & Medicaid Expansion of GLP-1 Access: A New Era for Diabetes and Weight Management February 29, 2024 Washington D.C. – Access to glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs initially developed for type 2 diabetes but increasingly used for weight management, is undergoing a significant shift within Medicare and Medicaid. The Centers … Read more

Medicare Part D 2026: Enrollment Shifts & What’s Changing

Medicare Part D Enrollment Surpasses 56 Million, Driven by Medicare Advantage Growth February 29, 2024 – New data released by the Centers for Medicare & Medicaid Services (CMS) reveals a significant milestone in Medicare Part D enrollment, exceeding 56 million beneficiaries as of February 2026. This surge is largely attributed to the increasing popularity of … Read more